As of 1:01pm ET
| -0.01 / -0.13%|
The 5 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 15.00, with a high estimate of 30.00 and a low estimate of 10.00. The median estimate represents a +96.59% increase from the last price of 7.63.
The current consensus among 5 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.